NKGEN BIOTECH News

10-Q: Quarterly report

May 20 17:02 ET

PRE 14A: Preliminary proxy statements relating to merger or acquisition

May 17 17:04 ET

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

May 15 16:15 ET

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 13 16:59 ET

8-K: Current report

May 13 08:09 ET

8-K: Current report

May 10 16:07 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Meteora Capital, LLC(0.0%),Vik Mittal(0.0%)

May 10 14:44 ET

10-K/A: Annual report (Amendment)

Apr 29 17:24 ET

8-K: Current report

Apr 29 16:06 ET

8-K: Current report

Apr 25 15:57 ET

10-K: Annual report

Apr 16 15:11 ET

NKGEN BIOTECH | 8-K: Current report

Apr 11 08:09 ET

NKGEN BIOTECH | 8-K: Current report

Apr 5 16:05 ET

NKGEN BIOTECH | NT 10-K: Others

Apr 1 16:03 ET

NKGEN BIOTECH | 8-K: Current report

Mar 27 17:00 ET

NKGEN BIOTECH | 8-K: Current report

Mar 20 16:04 ET

NKGEN BIOTECH | 8-K: Current report

Mar 15 17:07 ET

NKGEN BIOTECH | 8-K: Current report

Feb 22 16:03 ET

NKGEN BIOTECH | 8-K: Current report

Feb 20 12:26 ET

NKGEN BIOTECH | 4: Statement of changes in beneficial ownership of securities-Director Scott Kathleen D.

Feb 14 20:23 ET